|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 48/00 | |
| C07H 21/02 | |||
| C07H 21/04 |
| (11) | Number of the document | 3492109 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18213451.0 |
| Date of filing the European patent application | 2012-10-03 | |
| (97) | Date of publication of the European application | 2019-06-05 |
| (45) | Date of publication and mention of the grant of the patent | 2020-03-04 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201161542533 P | 2011-10-03 | US |
| (72) |
De Fougerolles, Antonin, US
Roy, Atanu, US
Schrum, Jason P., US
Siddiqi, Suhaib, US
Hatala, Paul, US
Bancel, Stephane, US
|
| (73) |
ModernaTX, Inc.,
200 Technology Square, Cambridge, MA 02139,
US
|
| (54) | MODIFIED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACIDS, AND USES THEREOF |
| MODIFIED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACIDS, AND USES THEREOF |